These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 21126196

  • 1. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.
    Steed MM, Tyagi SC.
    Antioxid Redox Signal; 2011 Oct 01; 15(7):1927-43. PubMed ID: 21126196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.
    Ovechkin AV, Tyagi N, Sen U, Lominadze D, Steed MM, Moshal KS, Tyagi SC.
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov 01; 291(5):L905-11. PubMed ID: 16815886
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells.
    Sen U, Tyagi N, Kumar M, Moshal KS, Rodriguez WE, Tyagi SC.
    Am J Physiol Cell Physiol; 2007 Dec 01; 293(6):C1779-87. PubMed ID: 17855772
    [Abstract] [Full Text] [Related]

  • 8. Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia.
    Moshal KS, Metreveli N, Frank I, Tyagi SC.
    Curr Vasc Pharmacol; 2008 Apr 01; 6(2):84-92. PubMed ID: 18393909
    [Abstract] [Full Text] [Related]

  • 9. Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
    Mishra PK, Tyagi N, Sen U, Joshua IG, Tyagi SC.
    Cardiovasc Diabetol; 2010 Sep 09; 9():49. PubMed ID: 20828387
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.
    Esse R, Barroso M, Tavares de Almeida I, Castro R.
    Int J Mol Sci; 2019 Feb 17; 20(4):. PubMed ID: 30781581
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.
    Tyagi N, Qipshidze N, Sen U, Rodriguez W, Ovechkin A, Tyagi SC.
    Int J Physiol Pathophysiol Pharmacol; 2011 Sep 30; 3(3):210-22. PubMed ID: 21941612
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes.
    Winchester L, Veeranki S, Givvimani S, Tyagi SC.
    Can J Physiol Pharmacol; 2014 Jul 30; 92(7):575-82. PubMed ID: 24923386
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia.
    Tyagi N, Moshal KS, Ovechkin AV, Rodriguez W, Steed M, Henderson B, Roberts AM, Joshua IG, Tyagi SC.
    J Cell Biochem; 2005 Nov 01; 96(4):665-71. PubMed ID: 16149054
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling.
    Vacek TP, Vacek JC, Tyagi SC.
    Arch Physiol Biochem; 2012 Feb 01; 118(1):31-42. PubMed ID: 22181043
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.